A Multicenter, Open Labeled, Randomized, Phase III Study Comparing Lopinavir/Ritonavir Plus Atazanavir to Lopinavir/Ritonavir Plus Zidovudine and Lamivudine in Naive HIV-1-Infected Patients: 48-Week Analysis of the LORAN Trial

OBJECTIVE: The primary aim of the study was to compare the metabolic side effects of a nucleoside analogue-containing regimen with a nucleoside analogue-sparing double protease inhibitor regimen. A secondary goal was to test for efficacy of a double-PI regimen. DESIGN: Multicenter, randomized, open-...

Descripción completa

Detalles Bibliográficos
Autores principales: Ulbricht, K.U, Behrens, G.M, Stoll, M, Salzberger, B, Jessen, H, Jessen, A.B, Kuhlmann, B, Heiken, H, Trein, A, Schmidt, R.E
Formato: Texto
Lenguaje:English
Publicado: Bentham Open 2011
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3103898/
https://www.ncbi.nlm.nih.gov/pubmed/21643422
http://dx.doi.org/10.2174/1874613601105010044

Ejemplares similares

Ejemplares similares